Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
3
×
drugs
life sciences
national blog main
alnylam pharmaceuticals
boston blog main
rna interference
accelerated approval
acute hepatic porphyria
alirocumab
amgen
aminolevulinic acid
biotech
boston
boston top stories
cannabidiol
dravet syndrome
epidiolex
evercore isi
evolocumab
fda
fen-phen
fenfluramine
givosiran
gw pharmaceuticals
heart attack
inclisiran
joseph swartz
lennox-gastaut syndrome
medicines co.
new york
new york blog main
new york top stories
pcsk9 inhibitors
regeneron pharmaceuticals
san francisco
san francisco blog main
san francisco top stories
stroke
svb leerink
What
data
3
×
drug
pharmaceuticals
3
×
alnylam
market
medicine
new
rna
ago
approved
based
battle
cannabis
cholesterol
cleared
derivative
epilepsy
evidence
far
fda
form
gw
gw’s
heart
interference
lasting
long
looms
lowering
marijuana
medco
medicines
nasdaq
ok
partner
presented
rare
reckoning
rnai
second
Language
Current search:
pharmaceuticals
×
data
×
" clinical trials "
×
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug